Back to results
US 2020/0390832 A1Published application
Composition for use in the treatment and/or improvement of sleep and mood disorders
AssigneeProbiotical S.P.A.
InventorsMarco PANE, Angela AMORUSO, Mirta FIORIO, Angela MAROTTA, Giovanna FELIS, Antonio DEL CASALE
Life of this patent
Estimating the term…
Abstract
The present invention refers to a composition for use in the treatment of sleep disorder, in particular, in the improvement of sleep quality. Furthermore, the present invention refers to a composition for use in the treatment of mood modulation
Claims11
A composition (C) comprising, a or alternatively, consisting of:
- (a) a bacteria strains mixture (M) comprising or, alternatively, consisting of at least one bacteria strain selected from among the group comprising or, alternatively, consisting of:
- (a-i) a bacterium strain of the Lactobacillus fermentum species identified as the Lactobacillus fermentum LF16 DSM 26956 bacterium strain;
- and/or
- (a-ii) a bacterium strain of the Lactobacillus plantarum species identified as the Lactobacillus plantarum LP01 LMG P-21021 bacterium strain;
- and/or
- (a-iii) a bacterium strain of the Lactobacillus plantarum species identified as the Lactobacillus plantarum LP02 LMG P-21020 bacterium strain;
- and/or
- (a-iv) a bacterium strain of the Lactobacillus rhamnosus species identified as the Lactobacillus rhamnosus LR06 DSM 21981 bacterium strain;
- and/or
- (a-v) a bacterium strain of the Bifidobacterium longum species identified as the Bifidobacterium longum BL04 DSM 23233 bacterium strain;
- and, optionally,
- (b) at least one technological additive and/or at least one pharmaceutical or food grade excipient,
- said composition (C) being for use in a method for curative and/or preventive treatment of mood modulation or mood dysregulation.
10 more elements
A method for modulating the mood of a subject, comprising administering to the subject a composition (C) comprising or, alternatively, consisting of:
- (a) a bacteria strains mixture (M) comprising or, alternatively, consisting of at least one bacteria strain selected from among the group comprising or, alternatively, consisting of:
- (a-i) a bacterium strain of the Lactobacillus fermentum species identified as the Lactobacillus fermentum LF16 DSM 26956 bacterium strain,
- (a-ii) a bacterium strain of the Lactobacillus plantarum species identified as the Lactobacillus plantarum LP01 LMG P-21021 bacterium strain,
- (a-iii) a bacterium strain of the Lactobacillus plantarum species identified as the Lactobacillus plantarum LP02 LMG P-21020 bacterium strain,
- (a-iv) a bacterium strain of the Lactobacillus rhamnosus species identified as the Lactobacillus rhamnosus LRO6 DSM 21981 bacterium strain;
- and
- (a-v) a bacterium strain of the Bifidobacterium longum species identified as the Bifidobacterium longum BL04 DSM 23233 bacterium strain;
- and, optionally,
- (b) at least one technological additive and/or at least one pharmaceutical or food grade excipient, to facilitate mood modulation in a subject.
6 more elements
Dependencies are inferred from the claim text.